Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada.
Pediatrics, St. Michael's Hospital, Toronto, Ontario, Canada.
BMJ Open. 2020 May 7;10(5):e035241. doi: 10.1136/bmjopen-2019-035241.
Cow's milk is a dietary staple for children in North America. Though clinical guidelines suggest children transition from whole (3.25% fat) milk to reduced (1% or 2%) fat milk at age 2 years, recent epidemiological evidence supports a link between whole milk consumption and lower adiposity in children. The purpose of this trial is to determine which milk fat recommendation minimises excess adiposity and optimises child nutrition and growth.
Cow's Milk Fat Obesity pRevention Trial will be a pragmatic, superiority, parallel group randomised controlled trial involving children receiving routine healthcare aged 2 to 4-5 years who are participating in the TARGet Kids! practice-based research network in Toronto, Canada. Children (n=534) will be randomised to receive one of two interventions: (1) a recommendation to consume whole milk or (2) a recommendation to consume reduced (1%) fat milk. The primary outcome is adiposity measured by body mass index z-score and waist circumference z-score; secondary outcomes will be cognitive development (using the Ages and Stages Questionnaire), vitamin D stores, cardiometabolic health (glucose, high-sensitivity C-reactive protein, non-high density lipoprotein (non-HDL), low density lipoprotein (LDL), triglyceride, HDL and total cholesterol, insulin and diastolic and systolic blood pressure), sugary beverage and total energy intake (measured by 24 hours dietary recall) and cost effectiveness. Outcomes will be measured 24 months postrandomisation and compared using analysis of covariance (ANCOVA), adjusting for baseline measures.
Ethics approval has been obtained from Unity Health Toronto and The Hospital for Sick Children. Results will be presented locally, nationally and internationally and published in a peer-reviewed journal. The findings may be helpful to nutrition guidelines for children in effort to reduce childhood obesity using a simple, inexpensive and scalable cow's milk fat intervention.
NCT03914807; pre-results.
牛奶是北美的儿童主要的饮食来源。尽管临床指南建议儿童在 2 岁时从全脂(3.25%脂肪)牛奶过渡到低脂(1%或 2%脂肪)牛奶,但最近的流行病学证据表明,全脂牛奶的消费与儿童的低肥胖率有关。本试验的目的是确定哪种牛奶脂肪推荐量能最大限度地减少肥胖,并优化儿童营养和生长。
牛奶脂肪肥胖预防试验将是一项实用的、优越性的、平行组随机对照试验,涉及在加拿大多伦多参与 TARGet Kids!基于实践的研究网络接受常规医疗保健的 2 至 4-5 岁儿童。儿童(n=534)将被随机分配接受以下两种干预措施之一:(1)建议饮用全脂牛奶,或(2)建议饮用低脂(1%)牛奶。主要结局是通过体重指数 z 评分和腰围 z 评分测量的肥胖程度;次要结局将是认知发育(使用年龄和阶段问卷)、维生素 D 储存、心脏代谢健康(葡萄糖、高敏 C 反应蛋白、非高密度脂蛋白(非 HDL)、低密度脂蛋白(LDL)、甘油三酯、高密度脂蛋白和总胆固醇、胰岛素和舒张压和收缩压)、含糖饮料和总能量摄入(通过 24 小时膳食回忆测量)和成本效益。在随机分组后 24 个月测量结果,并使用协方差分析(ANCOVA)进行比较,根据基线测量值进行调整。
已获得 Unity Health Toronto 和 The Hospital for Sick Children 的伦理批准。结果将在当地、全国和国际上进行展示,并发表在同行评议的期刊上。该研究结果可能有助于儿童营养指南,通过简单、廉价和可扩展的牛奶脂肪干预来减少儿童肥胖。
NCT03914807;预结果。